QUICK REFERENCE INSTRUCTIONS For use with Sofia only.

Similar documents
QUICK REFERENCE INSTRUCTIONS

QUICK REFERENCE INSTRUCTIONS For use with Sofia and Sofia 2. Rx only

Sofia Influenza A+B FIA

Next Generation Rapid Diagnostics

FOR USE WITH SOFIA AND SOFIA 2. For in vitro diagnostic use only. The Sofia Lyme FIA may be used with Sofia or Sofia 2.

Rapid Detection FAQs

Influenza A & B Screening

Sofia Lyme FIA. For use with Sofia Analyzer only CLIA Complexity: Moderate for serum and plasma specimens

For use with Sofia 2 CLIA Complexity: Waived for Finger-stick Whole Blood

contact your Medicare and B viral directly from samples. viruses: A, B,

FOR USE WITH SOFIA. For in vitro diagnostic use.

QUICK REFERENCE INSTRUCTIONS. THYROCHEK TSH Cassette

CLIA Waived for swab samples Non-Waived for Nasal Aspirate/Wash and swabs stored/transported in media.

Human Influenza A (Swine Flu) Rapid test

Rapid-VIDITEST. Influenza A+B

Rapid-VIDITEST Swine Flu

Rapid-VIDITEST. Influenza A

Step-by-Step Instructions For OraQuick HCV Rapid Antibody Test

G1 - Specimen collection

CLIA Complexity: Waived

NEPHROCHECK Liquid Control Kit Package Insert

CLIA Complexity: WAIVED INTENDED USE SUMMARY AND EXPLANATION

DETERMINE SPECIMEN REQUIREMENTS HIV-1/2 Ag/Ab Combo TESTING PROCEDURE

LeadCare BLOOD LEAD ANALYZER. Quick Reference Guide

For use with Sofia only

Abbott PXP Glucose Meters Resource: Lin Gustafson, MT(ASCP) Point of Care Coordinator, Laboratory

Rotavirus Test Kit. Instructions For Use. Format: Cassette Specimen: Fecal Extract Catalog Number: VEL-001-ROTA

NEPHROCHECK Calibration Verification Kit Package Insert

Tips for Training New Customers

Hepatitis C Virus (HCV) Antibody Test

Lilly. Disposable Insulin Delivery Device User Manual

Technical Bulletin. Technical Information for Quidel Molecular Influenza A+B Assay on the Bio-Rad CFX96 Touch

SAMPLE PROCEDURE 907-9, 06/11

Merry Christmas! Faith makes all. Hope makes all. Love makes all. things possible, things work, things beautiful,

CDIA TM Rubella IgG/IgM Rapid Test Kit

NEPHROCHECK Liquid Control Kit Package Insert

Strep-a-Test Twister Test

NexScreen Cup. Urine Drug Screen * READ POLICY PRIOR TO STARTING TUTORIAL

Rapid-VIDITEST. Astrovirus Card

PROCEDURE. TITLE: Bedside Glucose Monitoring PC Laboratory. Issuing Department: Clinical Director Signature: Departments Involved:

AVIAN INFLUENZA COMMODITIES TRAINING GUIDE MODULE 3 - SAMPLING, RAPID TESTING AND PACKAGING PARTICIPANT HANDOUTS

NEGATIVE POSITIVE. Rev , 06/11. 5 min. Mono Test. For fi ngertip. blood: 1 DROP 1 DROP For serum, whole blood. plasma or. samples.

TB LAM Ag Lateral Flow Assay Standard Operating Procedure

1. Intended Use New Influenza A virus real time RT-PCR Panel is used for the detection of universal influenza A virus, universal swine Influenza A vir

Helicobacter pylori Antigen Test

CLIA Complexity: WAIVED

Unigold Recombigen HIV 1/2 Training for HIV Testing Sites. Updated: February 2018 Cicely Richard Office of HIV/AIDS

To provide you with necessary knowledge and skills to accurately perform 3 HIV rapid tests and to determine HIV status.

ANTIBODY SCREENING by Uni-Gold Recombigen HIV

Catalog # 0W009 0W010 Test Cassettes, murine monoclonal antibody to human IgG (Test Line) and rabbit polyclonal antibody (Control Line)

Chlamydia trachomatis (CHLa)Test Kit

The FDA s New Reclassification of Rapid Influenza Diagnostic Tests: Are you Prepared?

CLIA Complexity: WAIVED

Dear HighQ Check System Owner :

Mono Test 1 DROP 1 DROP. For fingertip blood: For serum, plasma or whole blood samples in tubes: Rev , 05/09

HAV IgM Rapid Test(Cassette)

Rubella Latex Agglutination Test

PROCEDURE. Sekisui Diagnostics OSOM ifob Rapid Test. Title: Procedure #: Institution: Prepared by: Date: Title: Accepted by: Date adopted: Title:

Rapid-VIDITEST. Strep A Card. One step Strep A Card for the detection of Group A Streptococcal antigen from throat swabs or culture.

TITLE: Whole Blood Glucose Monitoring Using the Nova StatStrip Meter

Rapid-VIDITEST. Strep A Blister. One step Strep A Blister for the detection of Group A Streptococcal antigen from throat swabs or culture.

Sputum DNA Collection, Preservation and Isolation Kit 50 Individual Devices

Catalog # 0W009 0W010 Test Cassettes, murine monoclonal antibody to human IgG (Test Line) and rabbit polyclonal antibody (Control Line) Reagents

WHO Prequalification of Diagnostics Programme PUBLIC REPORT

Instructions For Use. SOLUTION FOR INJECTION IN PRE-FILLED PEN 250 micrograms

Guidelines for Sample Collection and Handling of Human Clinical samples for Laboratory Diagnosis of H1N1 Influenza

Rapid-VIDITEST. Rota-Adeno Blister. One Step Rotavirus and Adenovirus Antigen Blister test. Instruction manual

Fraser Health Authority Accu-chek Inform II: Training Script

CoaguChek S System. Quick Reference Guide. This is a CLIA-waived System. Coagulation Testing with Fresh Whole Blood

Virology Proficiency Testing Program. Restricted Category Direct Antigen Detection

Management of Central Venous Access Devices. Blood Glucose Monitoring

Sulfamethazine Test Kit 20 Tests

Items in the package:

CMV FEP ALA For nucleic acid amplification of CMV DNA and Fluorescence detection with End Point analysis (FEP) on Aladin (Sacace)

RG12T. For In Vitro Diagnostic Use. Passive Particle-Agglutination Test for Detection of Antibodies to HTLV-

Documenting Patient Immunization. New Brunswick 2018/19

ToxCup Drug Screen Cup (with and without Adulteration Tests) Training and Certification Program

Laboratory Name: Laboratory Address: Date of this packet: Insert Revision: IN Rev /12

Virology Proficiency Testing Program. Restricted Category Direct Antigen Detection

Title/Description: Point of Care Glucose Testing-Waived Department: Organization Wide Personnel: All Effective Date: November 29, 2016 Revised:

Product Training & Certification

Malaria Pf/pan antigen Rapid Test

QuickTox Drug Screen Dipcard (with and without Adulteration Tests)

DiagCORE Respiratory Panel 2. Instructions for use PL /2018-EN

PROCEDURE MANUAL. Prepared By Date Adopted Supersedes Procedure # Review Date Revision Date Signature

Documenting Patient Immunization. Ontario 2018/19

METHOD FOR THE MEASUREMENT OF BEDSIDE TROPONIN T (cobas h232)

ToxCup Drug Screen Cup (with and without Adulteration Tests) Training and Certification Program

GEX Recommended Procedure Eff. Date: 09/21/10 Rev.: D Pg. 1 of 7

Influenza A IgG ELISA

Blood glucose monitor. MediTouch 2

DEPARTMENT OF HEALTH AND MENTAL HYGIENE. nyc.gov/health

Blood Glucose Monitoring System. User Guide

WHO Prequalification of In Vitro Diagnostics PUBLIC REPORT. Product: OraQuick HIV 1/2 Rapid Antibody Test WHO reference number: PQDx

Protocols for Laboratory Verification of Performance of the FilmArray Respiratory Panel (RP) EZ

100 Years since the 1918 Spanish Flu Pandemic. Current Standards for Flu Pandemic Preparedness

i-stat CHEM8 + Cartridge Quick Reference Guide

WHO Prequalification of In Vitro Diagnostics PUBLIC REPORT. Product: OraQuick HIV 1/2 Rapid Antibody Test WHO reference number: PQDx

Transcription:

QUICK REFERENCE INSTRUCTIONS For use with Sofia only. CLIA Complexity: Waived Study the Package Insert and User Manual thoroughly before using Quick Reference Instructions. This is not a complete Package Insert. Test Procedure Note: The procedures for testing swab samples versus apirate/wash or samples in viral transport media are different. Read carefully. All clinical samples, including samples in VTM, must be at room temperature before testing. Expiration date: Check expiration on each individual test package or outer box before using. Do not use any test past the expiration date on the label. Swab Test Procedure (Nasal / Nasopharyngeal) 1 2 3 4 5 6 7 Verify that Sofia is set to the desired mode: WALK AWAY or READ NOW. See the "Using Sofia" section for more information. Dispense all of the Solution into the. Swirl the to dissolve its contents. Twist off Slowly Dispense Place the patient swab sample into the. Roll the Swab at least 3 times while pressing the head against the bottom and side of the. 3x Leave the Swab in the for 1 minute. Roll the swab head against the inside of the as you remove it. Dispose of the used swab in your biohazard waste. 3x Fill the provided Small, Clear 120 µl Fixed Volume Pipette with patient sample from the. To fill the Fixed Volume Pipette with the patient sample: a) FIRMLY squeeze the top bulb. b) Still squeezing, place the Pipette tip into the patient sample. c) With the Pipette tip still in the patient sample, slowly release pressure on bulb to fill the Pipette. 120 µl Pipette Firmly squeeze the top bulb to empty the contents of the Small, Clear 120 µl Fixed Volume Pipette into the Cassette sample well. Extra liquid left over in the overflow bulb should be left behind. NOTE: The Fixed Volume Pipettes are designed to collect and dispense the correct amount of liquid sample. Discard the Pipette in your biohazard waste. Promptly proceed to the next section, "Using Sofia," to complete the test. Solution in Bulb 1 Well Page 1 of 5

Nasopharyngeal Aspirate/Wash or s in Viral Transport Media Test Procedure 1 2 3 4 5 6 7 Verify that Sofia is set to the desired mode: WALK AWAY or READ NOW. See the "Using Sofia" section for more information. Also ensure that the liquid sample is at room temperature before proceeding. Dispense all of the Solution into the. Swirl the to dissolve its contents. Slowly Dispense Fill the provided Large, Pink 250 µl Fixed Volume Pipette with patient sample from the collection cup or test tube. To fill the Fixed Volume Pipette with the sample: a) FIRMLY squeeze the top bulb. b) Still squeezing, place the Pipette tip into the patient sample. c) With the Pipette tip still in the patient sample, slowly release pressure on the bulb to fill the Pipette. Note: To obtain accurate results, avoid mucoid substances when filling the Large, Pink Fixed Volume Pipette with patient sample from the collection cup. Firmly squeeze the top bulb to empty the contents of the Large, Pink 250 µl Fixed Volume Pipette into the. Extra liquid left over in the overflow bulb should be left behind. Note: Once the sample is added to the, vigorously mix prior to adding the sample to the test Cassette. NOTE: The Fixed Volume Pipettes are designed to collect and dispense the correct amount of liquid sample. Discard the Pipette in your biohazard waste. Fill the provided Small, Clear 120 µl Fixed Volume Pipette with patient sample from the, by slowly releasing pressure on the bulb. Firmly squeeze the top bulb to empty the contents of the Small, Clear Fixed Volume Pipette into the Cassette sample well. Note: Extra liquid left over in the overflow bulb should be left behind. Discard the Pipette in your biohazard waste. Promptly proceed to the next section, Using Sofia, to complete the test. Twist off 250 µl Pipette 250 µl Pipette 120 µl Pipette Solution in Bulb Well Page 2 of 5

A+B Eject A+B Using Sofia WALK AWAY/READ NOW Modes Refer to the Sofia User Manual for operating instructions. Sofia may be set to two different modes (WALK AWAY and READ NOW). The procedures for each mode are described below. WALK AWAY MODE In WALK AWAY Mode, the user immediately inserts the Cassette into Sofia. The user then returns after 15 minutes to get the test result. In this mode, Sofia will automatically time the test development before scanning and displaying the test result. 15 READ NOW MODE Critically important: Allow the test to develop for the full 15 minutes BEFORE placing it into Sofia. The user must first place the Cassette onto the counter or bench top for 15 minutes (outside of Sofia) and manually time this development step. Then, the user inserts the Cassette into Sofia. In READ NOW Mode, Sofia will scan and display the test result within 1 minute. Note: Results will remain stable for an additional 15 minutes after the recommended development time of 15 Minutes. 15 1 Page 3 of 5

Eject A+B Using Sofia (cont.) RUN TEST 1. Input the User ID using the barcode scanner or manually enter the data using the key pad. NOTE: If you mistakenly scan the incorrect barcode, use the Arrow Buttons on the Sofia key pad to re-highlight the field. Then simply rescan using the correct barcode, and the previous one will be overwritten with the correct barcode. B005 Operator ID 3. Press Start Test and the Sofia drawer will automatically open. 2. Input the ID or Order # using the barcode scanner or manually enter the data using the key pad. Interpretation of Results When the test is complete, the results will be displayed on the Sofia screen. The results can be automatically printed on the integrated printer if this option is selected. Test Lines, which are fluorescent, cannot be seen with the naked eye. The Sofia screen will display results for the procedural control being valid or invalid, and will individually provide a positive or negative result for both influenza A and influenza B. If the procedural control is invalid, retest with a new patient sample and a new Cassette. B005 Operator ID Display Flu A: Positive Flu B: Negative Flu A: Negative Flu B: Positive Flu A: Positive Flu B: Positive Flu A: Negative Flu B: Negative Flu A: Invalid Flu B: Invalid Procedural Control: Invalid 4. Verify that the correct development mode, WALK AWAY or READ NOW, has been selected. Insert the prepared patient test Cassette into the drawer of Sofia and close the drawer. 5. Sofia will start automatically and display the progress. In WALK AWAY Mode, the test results will be displayed on the screen in approximately 15 minutes. In READ NOW Mode, the test results will be displayed on the screen within 1 minute. See Interpretation of Results section. Interpretation Positive Test for Flu A (influenza A antigen present) Positive Test for Flu B (influenza B antigen present) Positive Test for both Flu A and Flu B* (influenza A and B antigen present) Negative Test for Flu A and Flu B (no antigen detected) Result Invalid *Co-infection with influenza A and B is rare. dual positive clinical specimens (influenza A and influenza B positive) should be re-tested with a new patient sample and a new test Cassette. Repeatable influenza A and B dual positive results should be confirmed by viral culture or an FDA-cleared influenza A and B molecular assay before reporting results. Page 4 of 5

External Quality Control (External Positive and Negative Swabs are supplied in the kit) 1 From the main menu, select Run QC. Following the prompt on the screen, scan the QC Card (located on the kit box). 2 3 4 5 Sofia will prompt the user to select the desired mode (WALK AWAY or READ NOW) and then to run the External Control Swabs. Follow the Swab Test procedure of this Quick Reference Instructions to test each Control Swab, first the Positive Control followed by the Negative Control. After both the Positive and Negative Swabs have been run, the results will be displayed as Passed or Failed. INTENDED USE The employs immunofluorescence to detect influenza A and influenza B viral nucleoprotein antigens in nasal swab, nasopharyngeal swab, and nasopharyngeal aspirate/wash specimens taken directly from symptomatic patients. This qualitative test is intended for use as an aid in the rapid differential diagnosis of acute influenza A and influenza B viral infections. The test is not intended to detect influenza C antigens. A negative test is presumptive and it is recommended these results be confirmed by viral culture or an FDA-cleared influenza A and B molecular assay. Negative results do not preclude influenza virus infections and should not be used as the sole basis for treatment or other patient management decisions. Performance characteristics for influenza A and B were established during February through March 2011 when influenza viruses A/California/7/2009 (2009 H1N1), A/Perth/16/2009 (H3N2), and B/ Brisbane/60/2008 (Victoria-Like) were the predominant influenza viruses in circulation according to the Morbidity and Mortality Weekly Report from the CDC entitled Update: Influenza Activity United States, 2010 2011 Season, and Composition of the 2011-2012 Influenza Vaccine. Performance characteristics may vary against other emerging influenza viruses. If infection with a novel influenza virus is suspected based on current clinical and epidemiological screening criteria recommended by public health authorities, specimens should be collected with appropriate infection control precautions for novel virulent influenza viruses and sent to state or local health department for testing. Viral culture should not be attempted in these cases unless a BSL 3+ facility is available to receive and culture samples. Reference the Package Insert for Warnings and Precautions, Specimen Collection and Handling, and Quality Control. CUSTOMER SERVICE If Sofia or the assay do not perform as expected, contact Quidel Technical Support 800.874.1517 (in the U.S.), 858.552.1100 (outside the U.S.), technicalsupport@quidel.com, or your local distributor. Study the Package Insert and User Manual thoroughly before using Quick Reference Instructions. This is not a complete Package Insert. Quidel Corporation San Diego, CA 92121 USA quidel.com 1219202EN00 (10/14) Page 5 of 5